Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A deeper mining on the protein composition of VA-MENGOC-BC®: An OMV-based vaccine againstN. meningitidisserogroup B and C

30 Oct 2017

Abstract excerpt

The protein composition of an Outer Membrane Vesicle (OMV) preparation that constitutes the active pharmaceutical ingredient of VA-MENGOC-BC®, an effective vaccine against Neisseria meningitidis serogroups B, and C is presented. This preparation has a high lipid content and five abundant membrane proteins (FetA, PorA, PorB, RmpM, and Opc), constituting approximately 70% of the total protein mass. The protein...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacterial Infections and Vaccines
Share to Microbial infections and disease research
Share to Pneumonia and Respiratory Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29083947
DOI: 10.1080/21645515.2017.1356961

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A deeper mining on the protein composition of VA-MENGOC-BC®: An OMV-based vaccine againstN. meningitidisserogroup B and CPMID 29083947Read ↗

Outer membrane vesicles of the VA‐MENGOC‐BC® vaccine against serogroup B <b><i>of Neisseria meningitidis</i></b>: Analysis of protein components by two‐dimensional gel electrophoresis and mass spectrometrySemantic proximity Read ↗

Proteomic analysis of outer membranes and vesicles from wild-type serogroup B Neisseria meningitidis and a lipopolysaccharide-deficient mutant.Semantic proximity Read ↗

Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254Semantic proximity Read ↗

Typing complex meningococcal vaccines to understand diversity and population structure of key vaccine antigensSemantic proximity Read ↗

Proteome analysis of Neisseria meningitidis serogroup A.Semantic proximity Read ↗

Comparative Proteome Analysis of Spontaneous Outer Membrane Vesicles and Purified Outer Membranes of Neisseria meningitidisSemantic proximity Read ↗

Induction of immune responses by purified outer membrane protein complexes from Neisseria meningitidis.Semantic proximity Read ↗

Proteomics-driven Antigen Discovery for Development of Vaccines Against GonorrheaSemantic proximity Read ↗

Towards the Immunoproteome of Neisseria meningitidisSemantic proximity Read ↗

Surfome Analysis as a Fast Track to Vaccine DiscoverySemantic proximity Read ↗

Bioinformatic analysis of meningococcal Msf and Opc to inform vaccine antigen design.Semantic proximity Read ↗

In Silico Prediction of a Multitope Vaccine against Moraxella catarrhalis: Reverse Vaccinology and ImmunoinformaticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.